March 31 (Reuters) - The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable ‌peptides that were banned because of potentially ...

A novel, minimally invasive method of determining whether fatty deposits in a coronary artery are restricting blood flow to a patient's heart performed similarly to the standard, more-invasive ...

The peptides, which are increasingly marketed as providing longevity and health benefits, were removed in 2023 from the agency’s list of products that compounding pharmacies can sell. By Christina ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

Elevated liver enzymes can be a sign of injury or inflammation of your liver. Alcohol, medications, or diseases are common causes of high liver enzymes. Lifestyle changes like regular exercise and a ...